• Molecular NameTriamcinolone_acetonide
  • SynonymFluoxiprednisolone; Fluoxyprednisolone; Tiamcinolonum [INN-Latin]; Triamcinalone; Triamcinolona [INN-Spanish]; Triamcinolone; Triamcinolone diacetate; Triamcinolone hexacetonide; Triamcinolonum [INN]
  • Weight420.477
  • Drugbank_IDN/A
  • ACS_NO76-25-5
  • Show 3D model
  • LogP (experiment)2.53
  • LogP (predicted, AB/LogP v2.0)2.47
  • pkaN/A
  • LogD (pH=7, predicted)2.47
  • Solubility (experiment)0.0213 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.69
  • LogSw (predicted, AB/LogsW2.0)0.17
  • Sw (mg/ml) (predicted, ACD/Labs)0.09
  • No.of HBond Donors2
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA93.06
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA more potent type of triamcinolone, being about 8 times as effective as prednisone. Triamcinolone acetonide should not be used by those with tuberculosis or untreated fungal, bacterial, viral or herpes infections without consulting a doctor first. Very few side effects were noted in clinical trials.
  • Absorption_value90.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability23.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A